Literature DB >> 7968541

pH-dependent permeabilization of the plasma membrane of mammalian cells by anthrax protective antigen.

J C Milne1, R J Collier.   

Abstract

Protective antigen (PA) of anthrax toxin forms ion-conductive channels in planar pan class="Chemical">lipid bilayers and liposomes under acidic pH conditions. We show here that PA has a similar permeabilizing action on the plasma membranes of CHO-K1 and three other mammalian cell lines (J774A.1, RAW264.7 and Vero). Changes in membrane permeability were evaluated by measuring the efflux of the K+ analogue, 86Rb+, from prelabelled cells, and the influx of 22Na+. The permeabilizing activity of PA was limited to a proteolytically activated form (PAN) and was dependent on acidic pH for membrane insertion (optimal at pH 5.0), but not for sustained ion flux. The flux was reduced in the presence of several known channel blockers: tetrabutyl-, tetrapentyl-, and tetrahexylammonium bromides. PAN facilitated the membrane translocation of anthrax edema factor under the same conditions that induced changes in membrane permeability to ions. These results indicate that PAN permeabilizes cellular membranes under conditions that are believed to prevail in the endosomal compartment of toxin-sensitive cells; and they provide a basis for more detailed studies of the relationship between channel formation and translocation of toxin effector moieties in vivo.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7968541     DOI: 10.1111/j.1365-2958.1993.tb00936.x

Source DB:  PubMed          Journal:  Mol Microbiol        ISSN: 0950-382X            Impact factor:   3.501


  49 in total

1.  Involvement of domain 3 in oligomerization by the protective antigen moiety of anthrax toxin.

Authors:  J Mogridge; M Mourez; R J Collier
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

2.  The C terminus of component C2II of Clostridium botulinum C2 toxin is essential for receptor binding.

Authors:  D Blöcker; H Barth; E Maier; R Benz; J T Barbieri; K Aktories
Journal:  Infect Immun       Date:  2000-08       Impact factor: 3.441

3.  The lethal and edema factors of anthrax toxin bind only to oligomeric forms of the protective antigen.

Authors:  Jeremy Mogridge; Kristina Cunningham; D Borden Lacy; Michael Mourez; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-07       Impact factor: 11.205

4.  Targeting HIV proteins to the major histocompatibility complex class I processing pathway with a novel gp120-anthrax toxin fusion protein.

Authors:  T J Goletz; K R Klimpel; N Arora; S H Leppla; J M Keith; J A Berzofsky
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-28       Impact factor: 11.205

5.  Membrane insertion by anthrax protective antigen in cultured cells.

Authors:  Maen Qa'dan; Kenneth A Christensen; Lei Zhang; Thomas M Roberts; R John Collier
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

6.  Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin.

Authors:  Wei Wang; Chandrika Mulakala; Sabrina C Ward; Grace Jung; Hai Luong; Duy Pham; Alan J Waring; Yiannis Kaznessis; Wuyuan Lu; Kenneth A Bradley; Robert I Lehrer
Journal:  J Biol Chem       Date:  2006-06-21       Impact factor: 5.157

7.  Identification and characterization of small molecules that inhibit intracellular toxin transport.

Authors:  Jose B Saenz; Teresa A Doggett; David B Haslam
Journal:  Infect Immun       Date:  2007-06-18       Impact factor: 3.441

8.  Assembly and disassembly kinetics of anthrax toxin complexes.

Authors:  Kenneth A Christensen; Bryan A Krantz; R John Collier
Journal:  Biochemistry       Date:  2006-02-21       Impact factor: 3.162

9.  Onset of anthrax toxin pore formation.

Authors:  Mu Gao; Klaus Schulten
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

10.  Phenylalanine-427 of anthrax protective antigen functions in both pore formation and protein translocation.

Authors:  Jianjun Sun; Alexander E Lang; Klaus Aktories; R John Collier
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-11       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.